logo
episode-header-image
Jun 2021
34m 21s

UK science policy shake-up; Ivermectin &...

Bbc Radio 4
About this episode

The Prime Minister has announced his desire for the UK to become a 'science superpower'. A new office within the cabinet to look at science will work alongside existing science strategy and funding structures. So far it's unclear where the responsibilities between the various science policy bodies lie. James Wilsdon, Professor of Research Policy at the University of Sheffield, helps Gaia Vince pick her way through the spaghetti of overlapping organisations and Dame Ottoline Leyser, UKRI Chief Executive, gives her her take of the impact of the reorganisation.

A major new trial has been announced into the effectiveness of the drug Ivermectin for the treatment of Covid-19. There's controversy surrounding the drug, which was designed to kill parasitic worms. It showed some promise against the virus in very limited lab studies. For many reluctant to vaccinate these studies seemed to suggest an alternative way to treat the virus. However, regulatory bodies disagree. It's hoped the new study and a range of other wide scale trials will give a more rounded view on the potential if any for Ivermectin as a Covid 19 treatment. Jack Goodman from the BBC News Misinformation Unit has been looking at the controversy surrounding Ivermectin. Scientists researching it have been subject to abuse and in some countries it has been rolled out as a treatment despite the lack of evidence on its effectiveness.

There have been reports of a number of cases of Black Fungus in patients with Covid-19 in India. What exactly is this unusual but life threatening fungal growth? Dr Nitin Gupta, Assistant Professor in Infectious Diseases at Kasturba Medical College in Manipal, South West India, explains why this previously rare infection is now on the rise..

Gaia Vince talks to Elena Zavala of the Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany about how she and her team have managed to extract DNA from samples of earth from the Denisovan cave in Siberia. Some years ago fragments of bone recovered from the cave revealed a new hominin species, called the Denisovans. Now DNA analysis of the layers of earth built up over hundreds of thousands of years are painting a picture of the vast variety of early people who used the cave, which included Neanderthals and early humans as well as Denisovans.

Up next
Jul 3
Can science save our oceans?
More than 2,000 marine scientists have come together at the One Ocean Science Congress in Nice, France. It is a gathering that will bring marine experts from all over the world together to share the latest discoveries about the health of our seas and oceans. It is an issue at the ... Show More
28m 11s
Jun 26
Your science questions answered
We’ve been rummaging through the Inside Science mailbox to pick out a selection of the intriguing science questions you’ve been sending in, and assembled an expert panel to try to answer them. Marnie Chesterton is joined by Penny Sarchet, managing editor of New Scientist, Mark Ma ... Show More
28m 7s
Jun 19
Does the pandemic agreement make the world safer?
The World Health Organisation has agreed a treaty looking at tackling the issue of future pandemics. It’s hoped it will help to avoid some of the disorganisation and competition for resources like vaccines and personal protective equipment that were seen during the Covid-19 outbr ... Show More
27m 59s
Recommended Episodes
Jun 2021
The Evidence: How Covid damages the human body
A year and a half in, and in many ways Covid-19 is still an enigma. All over the world, doctors and scientists are still struggling to understand exactly how this new virus undermines our defences and then damages, even destroys, our bodies, in so many different ways. And why are ... Show More
49m 58s
Jun 2020
Covid -19 hope for severe cases
A multi arm trial testing a range of drugs has shown that readily available steroids can be lifesaving for people severely ill with Covid-19. Max Parmar, head of the UK Medical Research Council’s clinical trials unit says the trial design, where many potential drugs can be tested ... Show More
1h 11m
May 2023
Darwin dumped from Indian classrooms
India is at the centre of much of the discussion on this week’s episode of Science In Action. We hear about how a proposal to scrap Darwinian evolution from Indian secondary schools has led to signatures from thousands of scientists. Dr Vineeta Bal, Researcher at the National Uni ... Show More
30m 34s
Nov 2022
Online harassment of Covid scientists
Since the Covid-19 pandemic began, scientists studying the virus have become targets of online harassment, and more recently, death threats. Roland speaks to Dr Angela Rasmussen, virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan, abou ... Show More
1h 1m
Sep 2021
New evidence for SARS-CoV-2’s origin in bats
Researchers studying bats in Northern Laos have found evidence that brings us closer than ever to understanding the origin of Covid-19. Since the beginning of the coronavirus pandemic scientists have tried to pin-point the exact origin of SARS-CoV-2. But recent evidence from the ... Show More
1h 3m
Nov 2022
Online harassment of Covid scientists
Since the Covid-19 pandemic began, scientists studying the virus have become targets of online harassment, and more recently, death threats. Roland speaks to Dr Angela Rasmussen, virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan, abou ... Show More
27m 16s
Mar 2021
The Life Scientific: Cath Noakes
Professor Cath Noakes studies how air moves and the infection risk associated with different ventilation systems. Early in the pandemic, she was invited to join the government’s Scientific Advisory Group for Emergencies, SAGE and asked to study the transmission routes for Covid-1 ... Show More
27m 25s
Jan 2020
The silence of the genes
In summer of 2019 NICE approved the use of a completely new class of drugs: the gene silencers. These compounds are transforming the lives of families who have rare debilitating – and sometimes fatal - diseases such as amyloidosis and porphyria. James Gallagher, BBC Health and Sc ... Show More
27m 21s